Global Glyburide Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glyburide Market Research Report 2024
Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II. It is typically given to patients who cannot be managed with the standard first line therapy, metformin. Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.
According to Mr Accuracy reports’s new survey, global Glyburide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glyburide market research.
Key manufacturers engaged in the Glyburide industry include Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu and Physicians Total Care, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Glyburide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Glyburide market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glyburide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR Sanjiu
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis
Segment by Type
1.25mg
2.5mg
5mg
Pediatric Use
Geriatric Use
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glyburide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Glyburide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glyburide market research.
Key manufacturers engaged in the Glyburide industry include Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu and Physicians Total Care, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Glyburide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Glyburide market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glyburide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR Sanjiu
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis
Segment by Type
1.25mg
2.5mg
5mg
Segment by Application
Pediatric Use
Geriatric Use
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glyburide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source